September 10, 2011

New Developments in Mesothelioma explore and Treatments

Cancer investigate and improvement is an ongoing process. In the field of mesothelioma treatment, researchers are focusing on enhancing original treatments as well as developing new techniques to ease the pain of patients. New chemotherapy agents and combination’s are now giving new hope to mesothelioma patients and are addition the survival rate amongst them. Any new advances have improved prognosis and rehabilitation of this incurable disease. Hoping for a cure in the near hereafter is therefore not something surreal.

Mesothelioma Law Suit

Computer tomography scans are not only a diagnostic tool in mesothelioma treatment. Ct Scans now enable the surgical team to accurately conclude the position of tumors in the anatomy of the patient. This enables cytoreduction to be more effective. Adequate cytoreduction is an principal prerequisite to enhancing the survival chances of the patient. The greater the amount of tumor cells that are removed, the less is the chances that the cancer grows and propagates.
Photodynamic Therapy (Pdt)

Photodynamic Therapy is one of the latest mesothelioma treatments being researched. Pdt makes use of a photosensitizer. This is a drug that produces active oxygen when exposed to a confident wavelength of light. Active oxygen destroys all nearby cells. When the sick person is treated with the photosensitizer (e.g. With porfimer sodium), the drug invades the whole body. However, by the very nature of the molecule, it remains attached to cancer cells for a longer period. Hence, after a period of 24-72 hours, when the agent has been removed from the general cells, the tumor is exposed to light (usually a laser transmitted to the tissue by a fiber optic cable carried by an endoscope). Active oxygen destroys the tumor cells directly with minimal damage to general cells. Pdt also helps to shrink tumors indirectly by destroying the blood vessels that furnish tumors and activating the immune theory to fight the tumor.

The benefit of Pdt is that it can be used repetitively with much less side effects than other treatments. The main drawback is that the light regularly cannot reach tumor cells that are more than 1 cm deep. Hence, Pdt is most productive in skin cancers and cancers found in the lining of internal organs or cavities. Fortunately, mesothelioma falls in this category.

Angiogenesis Inhibitors

Angiogenesis refers to the improvement of new blood vessels. Blood vessels are a principal factor in the increase of tumors. All malignant tumors develop their own vascular theory that carries nutrients from the bloodstream to the tumor, fuelling its growth. Controlling the improvement of these vascular systems has been an leading strategy in the fight against mesothelioma cancer. Angiogenesis inhibitors are drugs that block angiogenesis. This cuts off the furnish of oxygen and nutrients to the tumor whose increase immediately halts.
The benefit of angiogenesis inhibitors is that they are not as toxic as most other chemotherapy drugs. They can thus be given continuously to the sick person and are thus more productive in fighting the cancer. An example of an anti-angiogenesis drug under clinical trial for mesothelioma is bevacizumab (Avastin).

New Developments in Mesothelioma explore and Treatments

No comments:

Post a Comment